ROCKVILLE, Md.--(BUSINESS WIRE)--RegeneRx Biopharmaceuticals, Inc. (NYSE Amex:RGN) (“the Company” or “RegeneRx”) announced today that the Company will be participating in the Rodman & Renshaw 12th Annual Global Investment Conference being held at the Palace Hotel in New York City from September 13th – 15th, 2010. J.J. Finkelstein, RegeneRx’s president and chief executive officer, will deliver the Company’s corporate presentation on Tuesday, September 14th, at 10:00 a.m. (Eastern Time).
